Brochure | August 20, 2020

Customize Promega Bioluminescence Reagents To Optimize Your Workflow

Innovative Bioluminescence Technology
Promega has exploited the chemistry of the bioluminescent reaction to create a suite of robust and sensitive biological assays. We offer a number of luminescence output (“Glo”) assays for measuring cell health, cytotoxicity, apoptosis and other cellular events.

Our production team is experienced in the manufacturing and testing of luminescence-based ATP detection and reporter assay reagents. ATP reactions can be tailored for a variety of applications as broad as compound screening, ATP-based microbe testing, and biologic drug discovery and screening. Our bioluminescence platform provides you with many options. Promega luciferase technology is a fundamental platform on which many of our innovative products are built, from the earliest firefly luciferase assays to the Dual-Luciferase® Reporter Assays to the new NanoLuc® Luciferase and substrate. These assays have several advantages:

  • Highly sensitive—strong luminescence signal
  • Less prone to test compound interference than fluorescent assays
  • Amenable to automation and multiplexing with other assay technologies
VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: